Incyte Corp (INCY)

Add to Watchlists
Create an Alert
84.52 +1.40  +1.68% NASDAQ Aug 19, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/30/2019 08:00 EDT Misc Incyte Corp Third Quarter Earnings Conference Call in 2019
10/30/2019 Earnings Incyte Corp Third Quarter Earnings in 2019 Release
07/30/2019 08:00 EDT Misc Incyte Corp Second Quarter Earnings Conference Call in 2019
07/30/2019 Earnings Incyte Corp Second Quarter Earnings in 2019 Release
04/30/2019 08:00 EDT Misc Incyte Corp First Quarter Earnings Conference Call in 2019
04/30/2019 Earnings Incyte Corp First Quarter Earnings in 2019 Release
04/26/2019 13:00 EDT Misc Incyte Corp Annual General Meeting in 2018
02/14/2019 08:00 EST Misc Incyte Corp Fourth Quarter Earnings Conference Call in 2018
02/14/2019 Earnings Incyte Corp Fourth Quarter Earnings in 2018 Release
02/14/2019 Misc Incyte Corp Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.incyte.com
  • Investor Relations URL: http://www.incyte.com/ir/investor-overview.aspx
  • HQ State/Province: Delaware
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Oct. 30, 2019
  • Last Earnings Release: Jul. 30, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib.

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 5.31%
BBH VanEck Vectors Biotech ETF 4.80%
FBT First Trust NYSE Arca Biotech ETF 3.54%
IBB iShares Nasdaq Biotechnology ETF 2.48%
VGHCX Vanguard Health Care Inv 2.04%
SCGVX Sands Capital Global Growth Inv 1.94%
FGSCX Federated MDT Mid Cap Growth C 1.90%
RYH Invesco S&P 500® Equal Wt Hlth Care ETF 1.73%
XBI SPDR® S&P Biotech ETF 1.54%
FBIOX Fidelity® Select Biotechnology 1.42%
ATL1735 Renaissance Global Health Care Class O 1.40%
NMECX Nuveen Equity Market Neutral C 1.05%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("INCY","name")
  • Description: =YCI("INCY","description")
  • Sector: =YCI("INCY","sector")
  • Industry: =YCI("INCY","industry")
  • Est. Current Fiscal Year End: =YCI("INCY","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.